technical, we do welcome representatives of those patients, or parents
of patients, who serve as patient advocates. Their efforts have served
to make the scientific and medical community aware, not only of the
disease, but also of the issues surrounding it. They have made the
clinical community aware of the need for education and awareness of
the disease process, the need for new approaches to therapies and the
need for new understanding of the treatments currently used. The
patient advocates=E2=80=99 crusade has been instrumental in raising public =
and
professional awareness of the issues and has the potential to give a
voice to the larger numbers of people affected by the disease."
---------------------------------------------------------------------------=
-------------------------------------
http://medicine.tamhsc.edu/research/centers/ccdd/upcoming-events.html
October 13 - 14, 2011
POST-INFECTIOUS SYNDROMES AFFECTING COGNITION: WHAT IS THE
NEUROLOGICAL AFTERMATH OF POST-INFECTION?
This symposium will address potential links between the
=E2=80=9Cafter-effects=E2=80=9D post-infection and cognition, the nervous s=
ystem, and
behavior. As such, the Symposium has two purposes: (1) scientific
exchange in aid of understanding the mechanism(s) of chronic disease
and (2) physician education and awareness to improve diagnosis and
treatment of post-infectious syndromes. It is open to physicians,
psychiatrists, researchers, clinicians, medical and graduate students,
mental healthcare professionals, and interested public and/or patient
advocates. Day 2 will focus on post-infectious syndromes affecting the
nervous system in children. CME credits will be offered for each day
of the Symposium.
While the scientific sessions will be highly technical, we do welcome
representatives of those patients, or parents of patients, who serve
as patient advocates. Their efforts have served to make the scientific
and medical community aware, not only of the disease, but also of the
issues surrounding it. They have made the clinical community aware of
the need for education and awareness of the disease process, the need
for new approaches to therapies and the need for new understanding of
the treatments currently used. The patient advocates=E2=80=99 crusade has b=
een
instrumental in raising public and professional awareness of the
issues and has the potential to give a voice to the larger numbers of
people affected by the disease.
Due to the overwhelming response generated by this event and the space
constraints we face, a limit may have to be placed on the number of
scientific, medical professional, and patient advocate attendees, so
that we can accommodate only those that are officially registered for
the event. You may sign up for either Day 1 or Day 2 of the Symposium,
or both. Registrations will be taken on a first-come, first-serve
basis, by category. However, we will have video-recordings of the
event available for purchase after the symposium and possibly a live
webcast of the event itself.
PRELIMINARY AGENDA - Times will soon be announced and a website to
register, sign up for CME credits and reserve hotel accommodations
will be provided as it becomes available. All participants must
register through the registration website, regardless of whether they
desire CME credit or not.
Thursday, October 13, 2011
MEC Lecture Halls 1 & 2, Scott & White Hospital/ TAMHSC College of
Medicine, Temple, Texas
Friday, October 14, 2011
TAMHSC College of Medicine Medical School Auditorium, Round Rock
Campus, Round Rock, Texas
---------------------------------------------------------------------------=
-----
WHO SUFFERS FROM POST-INFECTIOIUS NEUROLOGICAL SYMPTOMS? WHY PROPER
DIAGNOSIS AND RESEARCH ARE CRITICAL
Confirmed speakers include the following, along with many other
distinguished participants:
W. Ian Lipkin, M.D., Keynote Speaker - Director of the Center for
Infection and Immunity, Columbia University
Sue Swedo, M.D., Keynote Speaker, Chief of the Pediatrics &
Developmental Neuroscience Branch at NIMH
Madeleine Cunningham, Ph.D., Keynote Speaker, Professor Microbiology
and Immunology University of Oklahoma Health Science Center
Margo Thienemann, M.D., pediatric psychiatrist, Stanford University
Brian Fallon, M.D. - Director, Center for the Study of
Neuroinflammatory Disorders & Biobehavioral Medicine, =E2=80=A8Columbia
University
Noel Rose, M.D. =E2=80=93 Director, Center for Autoimmune Disease Research,
Johns Hopkins University
Jack Antel, M.D. Montreal Neurological Institute and Hospital, McGill Unive=
rsity
Mady Hornig, M.D., Associate Professor of Epidemiology and Director of
Translational Research in the Center for Infection and Immunity,
Columbia University
Patrick Cleary, Ph.D., Professor Department of Microbiology,
University of Minnesota
Rita Cantor, Ph.D., Professor in Residence, David Geffen School of
Medicine UCLA, Neuropsychiatric Institute
Tanya Murphy, M.D., Professor and Director of Rothman Center for
Pediatric Neuropsychiatry, University of Southern Florida
Kyle Williams, M.D., Fellow, Albert J. Solnit Integrated Training
Program, Yale University
---------------------------------------------
Send posts to CO-CURE@listserv.nodak.edu
Unsubscribe at http://www.co-cure.org/unsub.htm
Co-Cure Archives: http://listserv.nodak.edu/archives/co-cure.html
---------------------------------------------
Co-Cure's purpose is to provide information from across the spectrum of
opinion concerning medical, research and political aspects of ME/CFS and/or
FMS. We take no position on the validity of any specific scientific or
political opinion expressed in Co-Cure posts, and we urge readers to
research the various opinions available before assuming any one
interpretation is definitive. The Co-Cure website <www.co-cure.org> has a
link to our complete archive of posts as well as articles of central
importance to the issues of our community.
---------------------------------------------
